Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 122

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 122
---
 our research and development activities, intellectual property and licenses, please see “ Item 4. B. Information on the
Company - Business Overview.”

D. Trend
Information

D& O insurance

Although in 2023 and 2024 there was a decrease in the cost of procuring
D& O liability insurance, in recent years we experienced an increase in such cost, resulting from a general increase in the cost of
D& O liability insurance for smaller, dual-listed public companies such as us. This general increase has been tied to perceived heightened
levels of risk for D& O insurers. Insurers have been increasing their level of compensation, in the form of premiums, which they believe
have not been commensurate with the risk being taken by them. In parallel, there has been an increase in the amounts of the deductibles
payable by public companies in situations in which an insurable event occurs. If this trend continues, it will increase our operational
expenses and have a negative effect on our financial results.

Market Risk

We are exposed to market risk from changes in exchange rates, interest
rates and inflation. We therefore continue to closely monitor the macro-economic conditions that result therefrom. We regularly assess
the implications of these local and global conditions on our operations, liquidity, cash flow and product candidates and seek to act to
mitigate any adverse consequences, to the extent possible, in a commercially reasonable manner, if and when applicable. All of these market
risks arise in the ordinary course of business, as we do not engage in speculative trading activities. Except as otherwise addressed herein,
such market risks are further discussed in Item 11 of this Annual Report under the section titled “ Quantitative and Qualitative
Disclosures about Market Risk”.

Other than as disclosed elsewhere in this Annual Report, we are
not aware of any trends, uncertainties, demands, commitments or events for the period from January 1, 2024 to December 31, 2024 that are
reasonably likely to have a material adverse effect on our revenues, profitability, liquidity or capital resources, or that caused the
disclosed financial information to be not necessarily indicative of future operating results or financial condition.

74

E. Critical
Accounting Estimates

We have provided a summary of our significant accounting policies,
estimates and judgments in Note 3 to our consolidated financial statements, which are included elsewhere in this Annual Report. The following
critical accounting discussion pertains to accounting policies management believes are most critical to the portrayal